This Clinical e-Audit is designed for GPs and helps identify which patients on long-term proton pump inhibitor (PPI) therapy could benefit from a step-down approach.
CLOSED FOR NEW ENROLMENTS
We are updating this Clinical e-Audit. A new version will be released in August 2018.
For current enrolment, submit Initial data collection, Review data collection and Evaluation by 30 April 2018.
RACGP 40 (Category 1) QI&CPD points (QI activity)Toggle information
This activity has been accredited for 40 (Category 1) points (QI activity) in the RACGP QI&CPD Program for the 2017–2019 triennium (activity ID number 92152).
ACRRM 30 PRPD pointsToggle information
This activity has been accredited for 30 PRPD points in the ACRRM PDP Program for the 2017–2019 triennium (7341).
- Recognised for the Practice Incentives Program Quality Prescribing Incentive (PIP QPI)
Proton pump inhibitors (PPIs) are one of the most widely prescribed medicines in Australia, commonly used to treat gastro-oesophageal reflux disease (GORD) and peptic ulcer disease.
Review 10 of your patients who are using a PPI and identify:
- those who may benefit from stopping or stepping down treatment
- where there is an indication for endoscopy or specialist review
- those who may need an increased dose or alternative medicine.
Our Clinical e-Audits are free quality improvement activities that help GPs review their current prescribing practice for patients with certain conditions, compared with current best practice guidelines.
- completing electronic data collection for 10 patients
- securely submitting de-identified data online
- receiving immediate patient-specific feedback to assist implementation of changes to practice
- reviewing individual and peer feedback results based on best practice clinical indicators
- recording progress of individual patients automatically identified for review
- reflecting on improvements in practice.
Participation in this activity will assist GPs to:
- detect and evaluate the continuing need for medicines that can cause or exacerbate gastric irritation and ulceration
- develop a systematic approach to identify patients prescribed a PPI in whom a step-down approach would be beneficial
- identify patients using a PPI who should be referred for endoscopy or specialist review
- recall potential common as well as rare but serious adverse effects of PPI therapy
- explore with patients the modification of lifestyle factors to improve gastro-oesophageal symptoms.